Vector Laboratories Attains ISO 9001:2015 Certification
Vector Laboratories, a Maravai LifeSciences company and leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today that it has achieved ISO 9001:2015 certification. This new designation for the company certifies a high level of quality assurance and consistency and will be particularly important to Vector customers who buy custom and OEM products used for research in diagnostic and pharmaceutical discovery.
ISO is the International Organization for Standardization, and certification is an important demonstration of Vector’s commitment to continuously deliver high-quality products. ISO standards help guide manufacturing and quality-control processes, documentation systems, customer service, product design and distribution and other support functions.
“We began the exhaustive process of getting this certification in 2016,” said Eric Tardif, president of Maravai LifeSciences. “Attaining the ISO designation is really a starting point because there are certain steps that must be taken every year to maintain certification and ensure continual improvement of processes. The discipline and documentation that are required will give our customers confidence and give us a competitive edge.”
“Following the ISO framework helps us improve productivity, enhance customer satisfaction and ensure business continuity,” said Ericka Crawford, VP of quality for Maravai LifeSciences. “It’s a win for us and a win for our customers.”
About Vector Laboratories
Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools to its customers for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, U.K., the company maintains a network of more than 40 distributors across the globe. Vector Laboratories was acquired by Maravai LifeSciences in 2016.
Contacts for the media:
David Weber, Chief Commercial Officer